Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

[Infectious diseases - a specialty of internal medicine].

Fätkenheuer G, Jung N, Kern WV, Fölsch UR, Salzberger B.

Internist (Berl). 2018 Apr;59(4):334-340. doi: 10.1007/s00108-018-0387-4. Review. German.

PMID:
29459991
2.

[Choosing Wisely: rationale, implementation, and evaluation].

Hasenfuß G, Fölsch UR.

Z Evid Fortbild Qual Gesundhwes. 2017 Dec;129:37-40. doi: 10.1016/j.zefq.2017.10.011. Epub 2017 Nov 20. German.

PMID:
29157561
3.

Klug Entscheiden-Initiative: Geschichte, Methodik, ethische Aspekte und internationale Verbreitung.

Hasenfuß G, Fölsch UR.

Z Evid Fortbild Qual Gesundhwes. 2017 Dec;129:1-2. doi: 10.1016/j.zefq.2017.11.001. Epub 2017 Nov 20. German. No abstract available.

PMID:
29157560
4.

[Representation of Internal Medicine in G-DRG System - Analysis of Reasons for Prolonged Length of Stay].

Siam K, Roeder N, Fölsch UR, Spies HF.

Dtsch Med Wochenschr. 2017 Aug;142(15):1144-1152. doi: 10.1055/s-0043-113120. Epub 2017 Aug 1. German.

PMID:
28763825
5.

[Choosing Wisely-evidence-based].

Hasenfuß G, Märker-Hermann E, Hallek M, Sieber CC, Fölsch UR.

Internist (Berl). 2017 Jun;58(6):525-526. doi: 10.1007/s00108-017-0253-9. German. No abstract available.

PMID:
28536760
6.

[Response to and further development of the Choosing wisely initiative].

Fölsch UR, Hallek M, Raupach T, Hasenfuß G.

Internist (Berl). 2017 Jun;58(6):527-531. doi: 10.1007/s00108-017-0246-8. Review. German.

PMID:
28477038
7.

[Erratum to: Flight and migration. A challenge for medicine in Germany].

Fölsch UR, Hasenfuß G, Spies HF, Wesiack W, Faulbaum F.

Internist (Berl). 2016 Oct;57(10):1036. German. No abstract available.

PMID:
27550189
8.

[Flight and migration : A challenge for medicine in Germany].

Fölsch UR, Hasenfuß G, Spies HF, Wesiack W, Faulbaum F.

Internist (Berl). 2016 Aug;57(8):822-30. doi: 10.1007/s00108-016-0103-1. German. Erratum in: Internist (Berl). 2016 Oct;57(10 ):1036.

PMID:
27435314
9.

[The Patient is not a customer and the hospital not a business center].

Schumm-Draeger PM, Mann K, Müller-Wieland D, Fölsch UR.

Dtsch Med Wochenschr. 2016 Aug;141(16):1183-5. doi: 10.1055/s-0042-111258. Epub 2016 Jul 14. German. No abstract available.

PMID:
27416542
10.

[Choosing wisely together with the patient].

Fölsch UR, Hasenfuß G.

Internist (Berl). 2016 Jun;57(6):540-50. doi: 10.1007/s00108-016-0069-z. German.

PMID:
27255446
11.

[Choosing wisely in internal medicine].

Hasenfuß G, Märker-Hermann E, Hallek M, Fölsch UR.

Internist (Berl). 2016 Jun;57(6):521-6. doi: 10.1007/s00108-016-0062-6. German.

PMID:
27251671
12.

English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis.

Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM; members of the guideline committee.

Z Gastroenterol. 2015 Dec;53(12):1447-95. doi: 10.1055/s-0041-107379. Epub 2015 Dec 14.

13.

[Future integrated health care in internal medicine: primary hypertension and polyangiitis with granulomatosis as modell diseases].

Raspe HH, Fölsch UR, Gross WL, Kirsten WD, Spies HF, Schumm-Draeger PM.

Dtsch Med Wochenschr. 2015 Jun;140(12):917-27. doi: 10.1055/s-0041-102338. Epub 2015 Jun 12. German. No abstract available.

PMID:
26069921
14.

[Drug safety and internal medicine].

Grandt D, Fölsch UR.

Dtsch Med Wochenschr. 2014 Oct;139(40):1976. doi: 10.1055/s-0034-1387218. Epub 2014 Sep 25. German. No abstract available.

PMID:
25254389
15.

["Physicians/Managers 2013": a study of the German Society of Internal Medicine].

Fölsch UR, Märker-Hermann E, Schumm-Draeger PM, Frey N, Müller-Quernheim J, Stüber E, Weber M, Broglie M, Kapitza T.

Dtsch Med Wochenschr. 2014 Apr;139(14):726-34. doi: 10.1055/s-0034-1369904. Epub 2014 Mar 25. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2014 Apr;139(14):e10. Märker-Hemann, E [corrected to Märker-Hermann, E].

PMID:
24668437
16.

[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)].

Chronic Pancreatitis German Society of Digestive and Metabolic Diseases (DGVS), Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM.

Z Gastroenterol. 2012 Nov;50(11):1176-224. doi: 10.1055/s-0032-1325479. Epub 2012 Nov 13. German. No abstract available.

PMID:
23150111
17.

A variant in the heart-specific fatty acid transport protein 6 is associated with lower fasting and postprandial TAG, blood pressure and left ventricular hypertrophy.

Auinger A, Helwig U, Pfeuffer M, Rubin D, Luedde M, Rausche T, Eddine El Mokhtari N, Fölsch UR, Schreiber S, Frey N, Schrezenmeir J.

Br J Nutr. 2012 May;107(10):1422-8. doi: 10.1017/S0007114511004727. Epub 2011 Sep 16.

PMID:
21920065
18.

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial.

Löhr JM, Haas SL, Bechstein WO, Bodoky G, Cwiertka K, Fischbach W, Fölsch UR, Jäger D, Osinsky D, Prausova J, Schmidt WE, Lutz MP; CT4001 Study Group.

Ann Oncol. 2012 May;23(5):1214-22. doi: 10.1093/annonc/mdr379. Epub 2011 Sep 6.

PMID:
21896540
19.

Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.

Jacobs G, Hellmig S, Huse K, Titz A, Franke A, Kwiatkowski R, Ott S, Kosmahl M, Fischbach W, Lucius R, Klapper W, Fölsch UR, Hampe J, Schreiber S, Rosenstiel P.

Haematologica. 2011 Jul;96(7):987-95. doi: 10.3324/haematol.2010.033126. Epub 2011 Apr 1.

20.

[New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)].

Fölsch UR, Nitschmann S.

Internist (Berl). 2010 Sep;51(9):1202-4. doi: 10.1007/s00108-010-2705-3. German. No abstract available.

PMID:
20658120
21.

Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel.

Rubin D, Helwig U, Nothnagel M, Fölsch UR, Schreiber S, Schrezenmeir J.

Eur J Endocrinol. 2010 Apr;162(4):719-27. doi: 10.1530/EJE-09-0446. Epub 2010 Jan 14.

PMID:
20075144
22.

S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

Schmiegel W, Pox C, Reinacher-Schick A, Adler G, Arnold D, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Heinemann V, Hohenberger W, Holstege A, Junginger T, Kopp I, Kühlbacher T, Porschen R, Propping P, Riemann JF, Rödel C, Sauer R, Sauerbruch T, Schmitt W, Schmoll HJ, Seufferlein T, Zeitz M, Selbmann HK; Federal Committee of Physicians and Health Insurers.

Z Gastroenterol. 2010 Jan;48(1):65-136. doi: 10.1055/s-0028-1109936. Epub 2010 Jan 13. No abstract available.

PMID:
20072998
23.

An internet portal for the development of clinical practice guidelines.

Höhne WJ, Karge T, Siegmund B, Preiss J, Hoffmann JC, Zeitz M, Fölsch UR.

Appl Clin Inform. 2010 Nov 24;1(4):430-41. doi: 10.4338/ACI-2010-04-RA-0027. Print 2010.

24.

G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation.

Sina C, Gavrilova O, Förster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Häsler R, Nikolaus S, Fölsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Rosenstiel P.

J Immunol. 2009 Dec 1;183(11):7514-22. doi: 10.4049/jimmunol.0900063. Epub 2009 Nov 16.

25.

Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.

Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts JH, Rosenstiel P, Franke A, Brosch M, Hinz S, Röder C, Kalthoff H, Fölsch UR, Krawczak M, Schreiber S, Bröring CD, Tepel J, Schafmayer C, Hampe J.

BMC Gastroenterol. 2009 Oct 20;9:79. doi: 10.1186/1471-230X-9-79.

26.

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).

Arlt A, Bauer I, Schafmayer C, Tepel J, Müerköster SS, Brosch M, Röder C, Kalthoff H, Hampe J, Moyer MP, Fölsch UR, Schäfer H.

Oncogene. 2009 Nov 12;28(45):3983-96. doi: 10.1038/onc.2009.264. Epub 2009 Sep 7.

PMID:
19734940
27.

Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB.

Sina C, Arlt A, Gavrilova O, Midtling E, Kruse ML, Müerköster SS, Kumar R, Fölsch UR, Schreiber S, Rosenstiel P, Schäfer H.

Inflamm Bowel Dis. 2010 Feb;16(2):320-331. doi: 10.1002/ibd.21066.

28.

Terminal part of thoracic duct: high-resolution US imaging.

Seeger M, Bewig B, Günther R, Schafmayer C, Vollnberg B, Rubin D, Hoell C, Schreiber S, Fölsch UR, Hampe J.

Radiology. 2009 Sep;252(3):897-904. doi: 10.1148/radiol.2531082036. Epub 2009 Jul 31.

PMID:
19703864
29.

The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis.

Steubesand N, Kiehne K, Brunke G, Pahl R, Reiss K, Herzig KH, Schubert S, Schreiber S, Fölsch UR, Rosenstiel P, Arlt A.

BMC Immunol. 2009 Jun 12;10:36. doi: 10.1186/1471-2172-10-36.

30.

Yersinia enterocolitica: another factor in the pathogenesis of chronic urticaria?

Hellmig S, Troch K, Ott SJ, Fölsch UR, Schwarz T.

Clin Exp Dermatol. 2009 Oct;34(7):e292. doi: 10.1111/j.1365-2230.2009.03226.x. Epub 2009 May 18. No abstract available.

PMID:
19456795
31.

Adult hereditary fructose intolerance.

Yasawy MI, Folsch UR, Schmidt WE, Schwend M.

World J Gastroenterol. 2009 May 21;15(19):2412-3.

32.

Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.

Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B, Fölsch UR, Schäfer H, Müerköster SS.

Cancer Res. 2009 May 15;69(10):4517-26. doi: 10.1158/0008-5472.CAN-08-3493. Epub 2009 May 12.

33.

Germline variations of the MALT1 gene as risk factors in the development of primary gastric B-cell lymphoma.

Hellmig S, Bartscht T, Fischbach W, Ott SJ, Rosenstiel P, Klapper W, Fölsch UR, Schreiber S.

Eur J Cancer. 2009 Jul;45(10):1865-70. doi: 10.1016/j.ejca.2009.03.010. Epub 2009 Apr 24.

PMID:
19394813
34.

Role of Helicobacter pylori Infection in the treatment and outcome of chronic urticaria.

Hellmig S, Troch K, Ott SJ, Schwarz T, Fölsch UR.

Helicobacter. 2008 Oct;13(5):341-5. doi: 10.1111/j.1523-5378.2008.00620.x.

PMID:
19250508
35.

alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.

Sebens Müerköster S, Kötteritzsch J, Geismann C, Gast D, Kruse ML, Altevogt P, Fölsch UR, Schäfer H.

Int J Oncol. 2009 Jan;34(1):243-53.

PMID:
19082495
36.

Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.

Kuehbacher T, Rehman A, Lepage P, Hellmig S, Fölsch UR, Schreiber S, Ott SJ.

J Med Microbiol. 2008 Dec;57(Pt 12):1569-76. doi: 10.1099/jmm.0.47719-0.

PMID:
19018031
37.

Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample.

Schafmayer C, Buch S, Völzke H, von Schönfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, Sipos B, Henopp T, Catalcali J, Hellmig S, ElSharawy A, Katalinic A, Lerch MM, John U, Fölsch UR, Fändrich F, Kalthoff H, Schreiber S, Krawczak M, Tepel J, Hampe J.

Int J Cancer. 2009 Jan 1;124(1):75-80. doi: 10.1002/ijc.23872.

38.

Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases.

Müerköster SS, Werbing V, Koch D, Sipos B, Ammerpohl O, Kalthoff H, Tsao MS, Fölsch UR, Schäfer H.

Int J Cancer. 2008 Oct 15;123(8):1751-60. doi: 10.1002/ijc.23703.

39.

Increased heritability of gallstone disease in early onset cases.

Schafmayer C, Freitag-Wolf S, Wolken H, Buch S, Brosch M, Egberts JH, Shekarriz H, Fölsch UR, Fändrich F, Krawczak M, Schreiber S, Tepel J, Hampe J.

Liver Int. 2008 Jul;28(6):895-7. doi: 10.1111/j.1478-3231.2007.01635.x. No abstract available.

PMID:
18647148
40.

Fatal pneumocystis jirovecii pneumonia in a case of ectopic Cushing's syndrome due to neuroendocrine carcinoma of the kidney.

Arlt A, Harbeck B, Anlauf M, Alkatout I, Klöppel G, Fölsch UR, Bewig B, Mönig H.

Exp Clin Endocrinol Diabetes. 2008 Oct;116(9):515-9. doi: 10.1055/s-2008-1062729. Epub 2008 Apr 1.

PMID:
18523920
41.

[Health system is being rearranged. What do you expect from the New Year?].

Weigeldt U, Blank W, Koch HH, Fölsch UR, Ahrens HJ, Strüngmann T, Köbele W.

MMW Fortschr Med. 2004 Jan 15;146(1-2):44-5, 47. German. No abstract available.

PMID:
18441575
42.

Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.

Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.

Acta Physiol (Oxf). 2008 Sep;194(1):57-65. doi: 10.1111/j.1748-1716.2008.01860.x. Epub 2008 Apr 3.

PMID:
18394026
43.

Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as risk factors for H. pylori-associated gastric MALT-lymphoma.

Hellmig S, Bartscht T, Fischbach W, Fölsch UR, Schreiber S.

Dig Dis Sci. 2008 Jul;53(7):2007-8. doi: 10.1007/s10620-008-0231-0. Epub 2008 Mar 13. No abstract available.

PMID:
18338261
44.

IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis.

Arlt A, Rosenstiel P, Kruse ML, Grohmann F, Minkenberg J, Perkins ND, Fölsch UR, Schreiber S, Schäfer H.

Biochim Biophys Acta. 2008 May;1783(5):941-52. doi: 10.1016/j.bbamcr.2007.12.010. Epub 2007 Dec 23.

45.

Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats.

Oikari S, Ahtialansaari T, Heinonen MV, Mauriala T, Auriola S, Kiehne K, Fölsch UR, Jänne J, Alhonen L, Herzig KH.

Pflugers Arch. 2008 May;456(2):369-77. Epub 2007 Dec 22.

PMID:
18157544
46.

Functional analysis of promoter variants in the microsomal triglyceride transfer protein (MTTP) gene.

Rubin D, Schneider-Muntau A, Klapper M, Nitz I, Helwig U, Fölsch UR, Schrezenmeir J, Döring F.

Hum Mutat. 2008 Jan;29(1):123-9.

PMID:
17854051
47.

Antimicrobial peptides in chronic anal fistula epithelium.

Kiehne K, Fincke A, Brunke G, Lange T, Fölsch UR, Herzig KH.

Scand J Gastroenterol. 2007 Sep;42(9):1063-9.

PMID:
17710671
48.

The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.

Sebens Müerköster S, Rausch AV, Isberner A, Minkenberg J, Blaszczuk E, Witt M, Fölsch UR, Schmitz F, Schäfer H, Arlt A.

Oncogene. 2008 Feb 14;27(8):1122-34. Epub 2007 Aug 20.

PMID:
17704804
49.

Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with -- 11388 promoter polymorphism.

Rubin D, Helwig U, Nothnagel M, Lemke N, Schreiber S, Fölsch UR, Döring F, Schrezenmeir J.

Br J Nutr. 2008 Jan;99(1):76-82. Epub 2007 Jul 30.

PMID:
17663805
50.

A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.

Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, Kluck C, Bässmann I, Brosch M, Lammert F, Miquel JF, Nervi F, Wittig M, Rosskopf D, Timm B, Höll C, Seeger M, ElSharawy A, Lu T, Egberts J, Fändrich F, Fölsch UR, Krawczak M, Schreiber S, Nürnberg P, Tepel J, Hampe J.

Nat Genet. 2007 Aug;39(8):995-9. Epub 2007 Jul 15.

PMID:
17632509

Supplemental Content

Loading ...
Support Center